Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heyan Kuntai Capsule for ovarian hypofunction
ChiCTR-OPB-17013916Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Feb 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Kuntai in primary ovarian insufficiency (POI), sponsored by Tongji Hospital. Primary endpoints: Anti-Mullerian hormone and Antral follicle count. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
Kuntai
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on ChiCTR-OPB-17013916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPB-17013916.